In the agreement, the US will help countries build their own health systems over the next five years and stop being overly ...
In the study, a once-daily, single-tablet combination of bictegravir and lenacapavir was as effective as Gilead's existing ...
The Phoenix City Council will weigh a proposal to prohibit handing out drug-testing kits and providing HIV testing in parks.
The Mirror US on MSN
North Carolina man with HIV rips out IV and sprays blood into eyes of hospital workers
"[Gilchrist] did unlawfully and willfully assault [the hospital workers] with a bodily fluid," the statement of charges, ...
Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...
Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...
For several years, pre-exposure prophylaxis against HIV (PrEP) has been a major success in preventing new cases. However, ...
Paper in @jclinicalinvest (bit.ly/497z6jo) by @HopkinsMedicine @JHUMed_ID finds patient living w/ #HIV has dramatic drop in ...
Over time, clonal expansion leads to an increase in the frequency of infected cells in a patient. The proviruses in daughter ...
A routine medical treatment descended into chaos at a Raleigh hospital after a patient ripped out his IV and deliberately sprayed his HIV-positive blood into ...
Nurse practitioners discuss evidence-based cancer screening and risk-reduction strategies that primary care clinicians can implement for patients with HIV.
Dec 15 () - Gilead Sciences said on Monday its experimental HIV treatment met the main goal in a late-stage trial. (Reporting by Sriparna Roy in Bengaluru; Editing by Tasim Zahid).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback